Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials.
Gogas BD, Bourantas CV, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns RJ, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston JA, Serruys PW. Gogas BD, et al. Among authors: onuma y. EuroIntervention. 2013 Oct;9(6):709-20. doi: 10.4244/EIJV9I6A115. EuroIntervention. 2013. PMID: 23628499 Free article.
The future of drug-eluting stents.
Kukreja N, Onuma Y, Daemen J, Serruys PW. Kukreja N, et al. Among authors: onuma y. Pharmacol Res. 2008 Mar;57(3):171-80. doi: 10.1016/j.phrs.2008.01.012. Epub 2008 Feb 2. Pharmacol Res. 2008. PMID: 18339557 Review.
828 results